MedTrace Logo

Study of Tranexamic Acid During Air and Ground Medical Prehospital Transport Trial (STAAMP Trial)

NCT02086500 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 903

Last updated 2020-09-10

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if 1 gram of prehospital tranexamic acid given during emergency medical transport to a level 1 trauma center in patients at risk of hemorrhage is associated with lower 30 day mortality.

Conditions

  • Traumatic Hemorrhage

Interventions

DRUG

Tranexamic Acid

1 gram of prehospital Tranexamic Acid

OTHER

Saline control

Saline Control

Sponsors & Collaborators

  • University of Arizona

    collaborator OTHER

  • The University of Texas at San Antonio

    collaborator OTHER

  • University of Utah

    collaborator OTHER

  • Jason Sperry

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2019-11-30
Completion
2019-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02086500 on ClinicalTrials.gov